Anticoagulation in venous thrombosis

Schulman, Sam
November 1996
Journal of the Royal Society of Medicine;Nov1996, Vol. 89 Issue 11, p624
Academic Journal
Major studies addressing various aspects of the treatment of deep vein thrombosis are reviewed. It has lately been demonstrated that heparin should be dosed according to body weight and is preferably given as subcutaneous injections twice daily. Alternatively, low-molecular-weight heparins may be given in a fixed dose once daily, which does not require monitoring. Oral anticoagulation should be started concomitantly with heparin and targeted at an international normalized ratio of 2.0-3.0. This treatment should continue for a longer duration than previously accepted, in many cases for 6 months. For patients with contraindications to oral anticoagulation, secondary prophylaxis with a low-molecular-weight heparin is also effective and safe.


Related Articles

  • clopidogrel.  // Royal Society of Medicine: Medicines;2002, p161 

    The article presents information on clopidogrel, an antiplatelet antithrombotic drug which is used to prevent thrombosis, but does not have an anticoagulant action. It works by stopping platelets sticking to one another or to the walls of blood vessels. It is used to reduce complications in...

  • dalteparin sodium.  // Royal Society of Medicine: Medicines;2002, p184 

    This article provides information on dalteparin sodium, a low molecular weight heparin which is used as an anticoagulant. It has some advantages over heparin when used in the long-term prevention of venous thrombo-embolism.

  • THE EFFECT OF REPOSITORY HEPARIN UPON LIPOPROTEIN PATTERNS IN HUMAN BEINGS. Loewe, Leo; Richmond, Gilbert; Brown, B. S. Raymond; Lasser, Richard P.; Cohen, Clifford; Cox, Herald // Angiology;Aug1953, Vol. 4 Issue 4, p295 

    In this study the marked effect of repository heparin upon the lipoprotein pattern of human beings has been demonstrated. It thus constitutes a confirmation of the initial observation of Graham et al. (7) in this regard. We have observed that the most pronounced effect is upon the lipoproteins...

  • Orally Ingested Heparin Is Absorbed in Humans. Engelberg, Hyman // Clinical & Applied Thrombosis/Hemostasis;Fall1995, Vol. 1 Issue 4, p283 

    It has been accepted for many years that orally ingested heparin is not absorbed. Recent evidence has shown that heparin placed in the stomach of rats is very rapidly absorbed and that it also quickly and almost completely attaches to the vascular endothelium and prevents jugular vein...

  • Flolan.  // Royal Society of Medicine: Medicines;2002, p249 

    The article provides information on Flolan, a proprietary, prescription-only preparation of the antiplatelet aggregation drug epoprostenol. It can be used to prevent formation of clots, for example, in conjunction with heparin in kidney dialysis, and is available in a form for intravenous infusion.

  • Management of Thrombotic and Cardiovascular Disorders in the New Millenium. Fareed, Jawed; Hoppensteadt, Debra A.; Bick, Rodger L. // Clinical & Applied Thrombosis/Hemostasis;Apr2003, Vol. 9 Issue 2, p101 

    Anticoagulants and antithrombotic drugs have played a key role in the prophylaxis, treatment and surgical/interventional management of thrombotic and cardiovascular disorders. There are several newer drugs which are currently developed for the anticoagulant management of cardiovascular diseases...

  • THE EFFECT OF SUBLINGUAL HEPARIN ON HYPERLIPEMIC SERUM. Shaftel, Herbert E.; Selman, David // Angiology;Jun1959, Vol. 10 Issue 3, p131 

    Examines the ability of sublingual heparin to clarify lipemic serum in a series of 36 patients under an acute experimental design. Determination of a base line curve of the serum turbidity after the ingestion of a standard fat test meal and after the administration of sublingual heparin;...

  • Is enoxaparin the superior low molecular weight heparin? Magill-Lewis, Jillene // Drug Topics;2/23/2004, Vol. 148 Issue 4, p40 

    Compares the effectiveness of the low molecular weight heparins enoxaparin and unfractionated heparin. Studies showing the superiority of enoxaparin over unfractionated heparin; Significant reductions in death, myocardial infarction, angina and the need for revascularization in the patients...

  • Clivarine.  // Royal Society of Medicine: Medicines;2002, p159 

    The article presents information on Clivarinel, a proprietary, prescription-only preparation of the anticoagulant reviparin sodium, which is a low molecular weight version of heparin. It can be used for long-duration prevention of deep-vein thrombosis. It is available in a form for subcutaneous...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics